0001209191-20-025176.txt : 20200420
0001209191-20-025176.hdr.sgml : 20200420
20200420195510
ACCESSION NUMBER: 0001209191-20-025176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200419
FILED AS OF DATE: 20200420
DATE AS OF CHANGE: 20200420
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RINGO WILLIAM R
CENTRAL INDEX KEY: 0001238325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 20803701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
DATE OF NAME CHANGE: 20020613
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-19
0
0001175505
FIVE PRIME THERAPEUTICS, INC.
FPRX
0001238325
RINGO WILLIAM R
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Employee Stock Option (right to buy)
2.80
2020-04-19
4
A
0
78408
0.00
A
2030-04-18
Common Stock
78408
78408
D
This option will vest in its entirety on May 19, 2020, subject to the reporting person's continued service to Five Prime Therapeutics, Inc. through such vest date.
/s/ Francis Sarena, Attorney-in-fact
2020-04-20